Accelerating Life Sciences R&D With Pega

Despite huge scientific advances and new technologies, biopharma R&D has been struggling for decades. The average annual output of approved new products per major pharmaceutical company had remained relatively flat for nearly 60 years – irrespective of the company’s size or level of R&D investment. Learn how industry leaders rely on Pega to change the game by connecting end-to-end lab data workflows, making clinical trials more efficient, reducing risk, and operationalizing quality management – to revolutionize R&D operations.